Literature DB >> 23652783

Haplotype analysis of PPARγ C681G and intron CT variants. Positive association with essential hypertension.

Q Zhu1, Z Guo, X Hu, M Wu, Q Chen, W Luo, J Liu.   

Abstract

BACKGROUND: There is strong evidence suggesting an association between the peroxisome-activated receptor γ (PPARγ) gene and multimetabolic disorders. The association of PPARγ genetic variants with essential hypertension (EH) has not yet been investigated. The aim of this study was to investigate the association between the PPARγ gene (C681G and intron CT) and EH, examining the polymorphism and haplotype in a Han Chinese population.
METHODS: Participants were recruited within the framework of the PMMJS cohort population survey in an urban community of Jiangsu Province, China. Two single-nucleotide polymorphisms (SNPs) previously reported to be associated with multimetabolic disorders and the reasonable coverage of the PPARγ gene region were analyzed with TaqMan SNP genotyping assays.
RESULTS: C681G and intron CT were significantly associated with an increased risk of EH both in the codominant model and the dominant model after adjusting for potential nongenetic risk factors. Analysis of the haplotype association revealed that the risk of EH was significantly increased among individuals carrying the GC (odds ratio, 95 % CI: 1.60, 1.21-2.11), CT (1.45, 1.03-2.11), and GT haplotypes (1.95, 1.17-3.23) compared with those carrying the CC haplotype.
CONCLUSION: The polymorphisms of C681G and intron CT were significantly associated with the risk of EH, and the GC, CT, and GT haplotypes established by C681G and intron CT are likely to be genetic markers of EH in the Han Chinese population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23652783     DOI: 10.1007/s00059-013-3819-x

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  23 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

2.  An intronic mutation responsible for a low level of expression of an HLA-A*24 allele.

Authors:  M Laforet; N Froelich; A Parissiadis; H Bausinger; B Pfeiffer; M M Tongio
Journal:  Tissue Antigens       Date:  1997-10

3.  A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans.

Authors:  A Meirhaeghe; L Fajas; N Helbecque; D Cottel; P Lebel; J Dallongeville; S Deeb; J Auwerx; P Amouyel
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

4.  Effect of pioglitazone on vascular reactivity in vivo and in vitro.

Authors:  T A Kotchen; H Y Zhang; S Reddy; R G Hoffmann
Journal:  Am J Physiol       Date:  1996-03

5.  SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.

Authors:  E R Martin; E H Lai; J R Gilbert; A R Rogala; A J Afshari; J Riley; K L Finch; J F Stevens; K J Livak; B D Slotterbeck; S H Slifer; L L Warren; P M Conneally; D E Schmechel; I Purvis; M A Pericak-Vance; A D Roses; J M Vance
Journal:  Am J Hum Genet       Date:  2000-06-21       Impact factor: 11.025

6.  Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect.

Authors:  T A Buchanan; W P Meehan; Y Y Jeng; D Yang; T M Chan; J L Nadler; S Scott; R K Rude; W A Hsueh
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 7.  Reactive oxygen species in vascular biology: implications in hypertension.

Authors:  R M Touyz; E L Schiffrin
Journal:  Histochem Cell Biol       Date:  2004-08-26       Impact factor: 4.304

8.  Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity.

Authors:  Chaim Yosefy; Eliahu Magen; Ada Kiselevich; Rita Priluk; Daniel London; Lior Volchek; Reuven J Viskoper
Journal:  J Cardiovasc Pharmacol       Date:  2004-08       Impact factor: 3.105

9.  Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus.

Authors:  Jagdip S Sidhu; Zoltan Kaposzta; Hugh S Markus; Juan Carlos Kaski
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-03-04       Impact factor: 8.311

Review 10.  The role of the angiotensin system in cardiac glucose homeostasis: therapeutic implications.

Authors:  Elena Bernobich; Luisa de Angelis; Carlos Lerin; Giuseppe Bellini
Journal:  Drugs       Date:  2002       Impact factor: 9.546

View more
  3 in total

1.  Case-control study on association of peroxisome proliferator-activated receptor-δ and SNP-SNP interactions with essential hypertension in Chinese Han population.

Authors:  Yubo Li; Guoqiang Sun
Journal:  Funct Integr Genomics       Date:  2015-11-27       Impact factor: 3.410

2.  Sex-specific association of rs4746172 of VCL gene with hypertension in two Han populations from Southern China.

Authors:  Qin Yu; Hong-Peng Sun; Wan-Qun Chen; Xiao-Qiong Chen; Yong Xu; Yong-Han He; Qing-Peng Kong
Journal:  Sci Rep       Date:  2015-10-21       Impact factor: 4.379

3.  Associations between hypertension and the peroxisome proliferator-activated receptor-δ (PPARD) gene rs7770619 C>T polymorphism in a Korean population.

Authors:  Minjoo Kim; Minkyung Kim; Hye Jin Yoo; Jayoung Shon; Jong Ho Lee
Journal:  Hum Genomics       Date:  2018-06-18       Impact factor: 4.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.